PPT-Opioids Part 2

Author : nasir | Published Date : 2024-10-30

MEd Pharmacokinetics Speed of onset is faster with increased lipid solubility Morphine Relatively low lipid solubility Only 1020 unionized at physiologic pH so doesnt

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Opioids Part 2" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Opioids Part 2: Transcript


MEd Pharmacokinetics Speed of onset is faster with increased lipid solubility Morphine Relatively low lipid solubility Only 1020 unionized at physiologic pH so doesnt diffuse into tissues quickly. Outpatient Opioid Therapy: Mitigating Risks. Perry G. Fine, MD . Professor . of Anesthesiology. Department . of . Anesthesiology . School . of Medicine. University of Utah. O. bjectives. Be informed of content, intent and limitation of current Clinical Guidelines. :. . Multimodal . Approaches . in . Clinical Practice. Acute Pain – Epidemiology. Acute pain is very common. 51.4 million surgical . in-patient. . procedures were performed in 2010 in the . United States . Asst.Prof. . Dr. Ghaith Ali Jasim. PhD Pharmacology. . OPIATES: Alkaloid found as a natural product in . Papaver. . somniferum. (Poppy. ), un-ripened seed pods. . . . NARCOTIC: Broader group of agents and is predominantly used by law enforcement to designate a variety of controlled substances with . Presentation provided by. Meldon. . Kahan. , MD. Family & Community Medicine. University of . T. oronto. CSAM-SCAM Fundamentals. Conflict of interest statement. Dr. Christy Sutherland . -. none. . Melissa B. Weimer, DO, MCR. Disclosures. Dr. Weimer is a consultant for . INFORMed. , IMPACT education, and the American Association of Addiction Psychiatry.. Dr. Weimer is the medical director of CODA, Inc. . Training of Trainers. Massachusetts Department of Public Health. Bureau of Substance Abuse Services. Agenda. Massachusetts Department of Public Health. Bureau of Substance Abuse Services. Understanding Opioids. Wayne Winegarden, Ph.D.. Sr. Fellow, Business & Economics, Pacific Research Institute. Contributing Editor, EconoSTATS a project of George Mason University. Partner, Capitol Economic Advisors. Presentation CWAG Annual Conference. Daniel Ford, PharmD, BCPS, BCCCP. Pharmacy Clinical Practice Manager. Pharmacy Residency Program Director. NorthBay Healthcare. ?. Itinerary. Stereotypes. Weekend Warrior. Long standing arthritic. “My . FDA’s Role and . Emerging Challenges. Jeanne Ireland. Principal, Ireland Strategies, LLC. 2015 CWAG Annual Meeting. The Opioid Epidemic. Some progress being made, but devastating effects of epidemic continue. CONVERSION FACTOR them together. 3 2 each opioid by the conversion factor. ( dosed in mcg/hr instead of mg/day, and HOW SHOULD PROVIDERS USE THE TOTAL DAILY OPIOID DOSE IN CLINICAL PRACTICE? Us Correspondence: Az Sint Jan Brugge-Oostende, Belgium, e-mail : jan.mulier@azsintjan.be, www.publicationslist.org/jan.mulier Analgesia, or being pain free, is only important postoperative when patients Types of Pain Acute pain usually occurs suddenly and has a known cause like an injury surgery or infection You may have experienced acute pain for example from a wisdom tooth extraction an outpatient Immersion Training in Addiction Medicine Programs 2021. May 2021. Daniel P. Alford, MD, MPH. Professor of Medicine. Associate Dean, Continuing Medical Education. Director, Clinical Addiction Research and Education (CARE) Unit. This program is funded by the Australian Government Department of Health.. Why is opioid stewardship important? . "Opioid use and misuse is having a critical impact on patients, their families and the health system. Every day in Australia, nearly 150 .

Download Document

Here is the link to download the presentation.
"Opioids Part 2"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents